GLANBIA Logo
IE0000669501
883867
GLB.L

GLANBIA

Previsión

No hay datos de analistas disponibles para esta empresa.

Debates en la comunidad

Todavía no hay ninguna discusión sobre este activo.

Iniciar debate

  • Glanbia raises 2026 forecast after strong first half

    Glanbia reported a strong first half with adjusted earnings per share of €0.8124 (+30% currency-adjusted) and revenue of €2.1bn (+7% currency-adjusted). Group EBITDA rose 14.1% currency-adjusted to €275.4m and the EBITDA margin improved to 13.2%. Drivers were strong demand for protein products, price stability at Optimum Nutrition and cost savings; management raised the full-year guidance for adjusted EPS to currency-adjusted growth of 17–20% and increased the transformation savings target to €70m per year by 2027. » Más en de.investing.com


  • Glanbia cuts Tirlán representation and reduces board size

    The Tirlán Co-operative Society is reducing its representation on the Glanbia board from two directors to one. John Murphy and Bill Carroll will resign on 4 August 2026; Ger O’Brien will be appointed on 5 August 2026 as a Tirlán‑nominated non‑executive director. After the changes, the board will consist of ten directors (two executive, the chair and seven non‑executive, one of whom is from Tirlán). Glanbia reports no further matters requiring disclosure. » Más en de.investing.com


  • Tirlán sells 12 million Glanbia shares for €257.6 million

    The Tirlán Co-operative Society has completed the sale of 12,000,000 ordinary shares in Glanbia for a total of around €257.6 million. 9,671,170 shares were sold to institutional investors via an accelerated bookbuild, and 2,328,830 shares were sold off‑market to Glanbia as part of an approved targeted buyback; the price for both transactions was €21.47 per share. After settlement (expected around 16 June 2026) and the cancellation of the shares acquired by the company, Tirlán will remain the largest shareholder with 31,548,762 ordinary shares; the cancellation will reduce issued ordinary shares to an expected 239,613,665 and will use €50 million of the ongoing €100 million buyback program. » Más en de.investing.com


  • Glanbia: Tirlán to sell around 5% (approx. 12 million shares), Glanbia to buy up to €50m off-market

    The Tirlán Co-operative Society plans to sell about 12 million Glanbia shares (≈5% of capital) via an accelerated placement to institutional investors and an off-market sale to Glanbia of up to €50 million. The off-market purchase will be made under an already approved buyback programme and is conditional on completion of the placement; all shares acquired by Glanbia will be cancelled. The price for the off-market purchase will be based on the bookbuilding price; after completion Glanbia intends to disclose the number and price of the shares acquired. » Más en de.investing.com


  • Glanbia launches buyback programme of up to €50 million

    Glanbia has launched a share buyback programme of up to €50 million, which starts today and runs until 30 September 2026. Shares acquired will be cancelled to reduce share capital; J&E Davy will execute purchases as principal within set parameters and will make buy decisions independently of the company, including during closed trading periods. The programme is part of an overall €100 million initiative and is being carried out under an existing shareholder authorisation that expires at the end of April 2026 and must be renewed for continuation. » Más en de.investing.com

En 2026, GLANBIA ya ha pagado 0,45 € en dividendos. El último pago fue en octubre.

Datos financieros

En el último trimestre, GLANBIA tuvo unos ingresos de 2037,65 M € y un beneficio neto de 150,71 M €

(EUR) junio de 2026
YoY
Ingresos 2037,65 M -
Beneficio bruto 542,97 M -
Beneficio neto 150,71 M -
EBITDA 273,2 M -

Datos fundamentales

Métrica Valor
Capitalización bursátil
4713,77 M €
Número de acciones
236,87 M
Máximo/mínimo de 52 semanas
25,60 € - 13,30 €
Rentabilidad por dividendo
2,19 %
Dividendos TTM
0,45 €
Beta
0,45
Ratio P/E
21,74
Ratio PEG
0,20
Ratio P/B
2,71
Ratio P/S
1,24

Perfil de la empresa

Glanbia plc opera como empresa de nutrición a nivel mundial. La compañía fabrica y vende productos de nutrición deportiva y de nutrición para el estilo de vida en diversos formatos, incluidos polvos, barritas listas para consumir y alimentos para picar, y bebidas listas para beber a través de diversos canales, como comercios especializados, venta en línea y gimnasios, así como los canales de alimentación, farmacias, venta masiva y clubes. Se dedica a la fabricación y venta de queso, ingredientes nutricionales y funcionales lácteos y no lácteos, y premezclas de vitaminas y minerales. Además, la compañía se dedica a las actividades de financiación, investigación y desarrollo, compraventa de inmuebles y terrenos, gestión de cuentas por cobrar, gestión, arrendamiento de inmuebles, servicios empresariales y soluciones de control de peso. Gestiona una cartera de marcas, entre ellas OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass y las marcas BODY&FIT. Glanbia plc se fundó en 1964 y tiene su sede central en Kilkenny, Irlanda.

Nombre
GLANBIA
CEO
Hugh McGuire Finance
Sede Kilkenny, kk
Irlanda
Sitio web
Salida a bolsa
04/01/2000
Empleados 5800

Símbolos bursátiles

Bolsa Símbolo
London Stock Exchange
GLB.L
Pnk
GLAPF
Frankfurt
GL9.F
Düsseldorf
GL9.DU
London
GLB.L
München
GL9.MU
🍪

Parqet  usa cookies. Más información